LEADER 01118nam0 22002773i 450 
001 VAN0239532
005 20220209094955.324
017 70$2N$a978-3-030-78605-2
100   $a20220207d2021       |0itac50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
200 1 $aRare Disease Drug Development$eClinical, Scientific, Patient, and Caregiver Perspectives$fRaymond A. Huml editor
210   $aCham$cSpringer$d2021
215   $aXXIV, 409 p.$cill.$d24 cm
620   $aCH$dCham$3VANL001889
702  1$aHuml$bRaymond A.$3VANV182218
712   $aSpringer <editore>$3VANV108073$4650
801   $aIT$bSOL$c20240614$gRICA
856 4 $uhttps://link.springer.com/book/10.1007/978-3-030-78605-2$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15
912   $fN
912   $aVAN0239532
950   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS      SBA EBOOK 8478                      $e15EB 8478              20220207            
996   $aRare Disease Drug Development$92587208
997   $aUNICAMPANIA